Noman Paracha

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 5

Top Topics

Positive Breast Cancer

Health Insurance

Decision Making

Top Venues

JCO precision oncology

PharmacoEconomics

Breast cancer research and treatment

This page only lists publications with an associated author ORCID identifier.

Publications

Carsten Bokemeyer, Noman Paracha, Ulrik N Lassen, Antoine Italiano, Sean D Sullivan, Marisca Marian, Nicoletta Brega, Jesús García-Foncillas
Survival Outcomes of Patients With Tropomyosin Receptor Kinase Fusion-Positive Cancer Receiving Larotrectinib Versus Standard of Care: A Matching-Adjusted Indirect Comparison Using Real-World Data. JCO precision oncology 7 (2023)
Ulrik N Lassen, Carsten Bokemeyer, Jesús García-Foncillas, Antoine Italiano, Gilles Vassal, Noman Paracha, Marisca Marian, Yuxian Chen, Louise Linsell, Keith R Abrams
Prognostic Value of Neurotrophic Tyrosine Receptor Kinase Gene Fusions in Solid Tumors for Overall Survival: A Systematic Review and Meta-Analysis. JCO precision oncology 7 (2023)
Carsten Bokemeyer, Noman Paracha, Ulrik N Lassen, Antoine Italiano, Sean D Sullivan, Marisca Marian, Nicoletta Brega, Jesús García-Foncillas
Survival Outcomes of Patients With Tropomyosin Receptor Kinase Fusion-Positive Cancer Receiving Larotrectinib Versus Standard of Care: A Matching-Adjusted Indirect Comparison Using Real-World Data. JCO precision oncology 7 (2023)
Siu Hing Lo, Ksenija Gorni, C Simone Sutherland, Yasmina Martí, Andrew J Lloyd, Noman Paracha
Preferences and Utilities for Treatment Attributes in Type 2 and Non-ambulatory Type 3 Spinal Muscular Atrophy in the United Kingdom. PharmacoEconomics (2021)
Noman Paracha, Adriana Reyes, Véronique Diéras, Ian Krop, Xavier Pivot, Ander Urruticoechea
Evaluating the clinical effectiveness and safety of various HER2-targeted regimens after prior taxane/trastuzumab in patients with previously treated, unresectable, or metastatic HER2-positive breast cancer: a systematic review and network meta-analysis. Breast cancer research and treatment 180 (3) (2020)